Home > Healthcare & Medical Devices > U.S. Clinical Nutrition Market
U.S. Clinical Nutrition Market size crossed USD 11.5 billion in 2021 and is projected to depict more than 8.5% CAGR through 2022-2030.
There is a rising burden of chronic non-communicable diseases across the region. Scientific discoveries about the association of dietary components and cellular mechanisms of illnesses are contributing to the acceptance of clinical nutrition as a multidisciplinary approach to preventing obesity. This approach can also be adopted for the treatment of co-morbidities related to obesity, such as diabetes, hypertension, and cardiovascular conditions. With the increased prevalence of diet-related chronic diseases, the rate of clinical nutrition assessment will gain momentum in countries including the United States.
To get more details on this report: Request Free Sample PDF
Based on data from the Centers for Disease Control and Prevention, in 2019, over 28.7 million people, or 8.7% of the U.S. population were diagnosed with diabetes. The management of this chronic disease is multidimensional and comprises various treatment options including clinical nutrition. The surge in the incidence rate of non-communicable diseases, which can lead to prolonged hospitalization and high mortality rates, will thus contribute to the development of clinical nutrition centers across the nation.
|Market Size in 2021:||11.8 Million (USD)|
|Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||8.5%|
|2030 Value Projection:||23.5 Billion (USD)|
|Historical Data for:||2017 to 2021|
|No. of Pages:||89|
|Tables, Charts & Figures:||67|
|Segments covered:||Product, Consumer, Application, Distribution Channel, and Region|
|Pitfalls & Challenges:|
To get details on how to order this report click here
Regulatory bodies, however, have introduced strict mandates related to the sale of clinical nutrition products. The U.S. Food and Drug Administration, for example, has more regulations for clinical nutrition products under the DSHEA (Dietary Supplement Health and Education Act of 1994) than other items including drugs and conventional foods. This strict regulatory framework related to nutritional products may impede the industry development to some extent.
To tailor this report to your specific requirements: Customize this Report
U.S. clinical nutrition market from infant nutrition segment was more than USD 6 billion in 2021, given the rise in cases of preterm birth. According to statistics from the CDC, in 2020, preterm birth impacted 1 in 10 infants in the U.S. Clinical nutritionists attend to these neonates to lower the risk of developmental problems and provide metabolic and immunogenic care. As the number of premature babies grows, the adoption of clinical nutrition for infants is expected to surge to support their optimal growth.
U.S. clinical nutrition market from the pediatric consumer segment is anticipated to reach USD 14 billion by 2030. The surging rate of premature birth and the subsequent increase in the requirement for neonatal nutrition is propelling the segment outlook in the U.S. Due to compromised immune systems, premature babies are susceptible to chronic health conditions. The rising awareness about potential complications for preterm infants will thus escalate the reliance on clinical nutrition and dietetics across the region.
U.S. clinical nutrition market from the metabolic disorders application segment is anticipated to cross USD 7.5 billion by 2030. This is a result of the strong awareness about the advantages of clinical nutrition products in the precise management of metabolic ailments. In healthcare settings, nutrition is vital for patients with metabolic disorders, to boost their immunity, prevent malnutrition, and manage their disease. With the incidence rate of metabolic disorders growing steadily across the U.S., the establishment of clinical nutrition centers will witness significant progress.
To check discounted pricing for this report: Request Discount
U.S. clinical nutrition market share from the retail stores distribution channel segment is expected to surpass USD 10 billion by 2030. Retail outlets can provide customers with seamless access to clinical nutritional supplements, as a wide product range is offered. Retailers also help key brands expand their geographical reach to cater to a vast consumer base. The distribution channel further enables businesses to benefit from reduced distribution and stockholding costs. These advantages will augment the sales of nutritional supplements from retail channels.
Abbott Laboratories (Abbott Nutrition), Mead Johnson (Reckitt Benckiser), Baxter International Inc., Fresenius Kabi, B Braun Melsungen AG, Nestle Health Science, Hero Nutritionals Inc., Perrigo, Pfizer, Inc., and Danone are some of the key players operating in the U.S. clinical nutrition market. These companies are focusing on mergers and acquisitions, among other strategies, to strengthen their footprint in the market.
The COVID-19 outbreak has asserted an unprecedented impact on the healthcare industry. In the initial months of the pandemic, alternative treatment procedures were temporarily put on hold, to reduce the incidence and mortality rates of coronavirus infections. However, there has been a growing awareness about the role of nutrients in supporting the immune system in COVID-19-infected patients since the onset of the crisis. In 2020, the American Society for Clinical Nutrition and Metabolism issued recommendations for the nutritional management of individuals infected with the coronavirus, generating opportunities for the industry.
U.S. clinical nutrition market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments: Click here to buy sections of this report
Click here to buy sections of this report
By Distribution Channel